Board Member
Protagonist Therapeutics, Inc (PTGX)Equibles does not estimate personal net worth.
Get an email with a short summary when Protagonist Therapeutics, Inc publishes a filing, an earnings call transcript or a press release.
Get PTGX alertsDinesh Patel is recorded as CEO and Board Member at Protagonist Therapeutics, Inc (PTGX). The proxy statement of Protagonist Therapeutics, Inc reports total compensation of $12,871,506 for Dinesh Patel in fiscal 2025, including a base salary of $715,500. Disclosed compensation is on record for 8 fiscal years. Dinesh Patel has spoken on 2 earnings calls and 2 other investor events across 1 company, most recently for Protagonist Therapeutics, Inc on June 3, 2026. Protagonist Therapeutics, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Protagonist Therapeutics, Inc includes Dinesh V. Patel (CEO and Board Member), Asif Ali (CFO), Daniel N. Swisher, Jr. (Board Member) and 5 others.
“In a way, we can also claim to be a company with a commercial presence with the approval of IcoTide that is partnered with J&J and with Resfetide partnered with Takeda.”
“First and foremost, thanks for inviting us. And I have to mention that this does take me down memory lane. You know, protagonists, we did our IPO back in 2016, and Barclays was one of the bank that helped us achieve that component of going public.”
“Good afternoon, everyone, and thank you all for joining our conference call to discuss Protagonist Therapeutics’ financial results and corporate highlights for the fourth quarter and full year 2020.”
“On today's call, we'll also hear from Samuel Saks, our Chief Medical Officer; and Dr. Ronald Hoffman, Professor of Medicine in Hematology and Medical Oncology at the Mount Sinai Hospital in New York City.”
Biotechnology · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $715,500 | $12,871,506 |
| 2024 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $681,410 | $9,473,819 |
| 2023 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $655,200 | $7,067,572 |
| 2022 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $630,000 | $5,993,238 |
| 2021 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $600,000 | $5,544,733 |
| 2020 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $565,000 | $2,225,622 |
| 2019 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $545,000 | $1,948,344 |
| 2018 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $520,000 | $3,721,511 |
